S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/Deep Track Capital/Q4 2022

Deep Track Capital

Periodo: Q4 2022 Β· Depositato: 2023-02-14
Vedi su SEC EDGAR β†—
AUM
$2.38B
Valore totale del portafoglio
Posizioni
60
Titoli dichiarati
Prima Posizione
IMVT
7.2% $172.3M
Var. Trimestrali
+8 / -8
nuovi Β· usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR β€” non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquiditΓ , obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato Γ¨ il valore nozionale delle azioni sottostanti β€” non il premio pagato. CiΓ² sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo Γ¨ tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con β‰₯$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker Γ¨ a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2023-02-14) si riferisce al titolo sottostante β€” non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
IMVTIMMUNOVANT INC$172.3M7.24%$18.75$38.79+106.9%
7.2%
ISEEIVERIC BIO INC$168.7M7.08%β€”β€”
7.1%
JAZZJAZZ PHARMACEUTICALS PLC$139.2M5.84%$156.36$243.47+55.7%
5.8%
TVTXTRAVERE THERAPEUTICS INC$96.4M4.05%$20.66$56.92+175.5%
4.0%
ASNDASCENDIS PHARMA A/S$85.5M3.59%$120.72$274.50+127.4%
3.6%
INSMINSMED INC$85.2M3.58%$19.18$111.60+481.9%
3.6%
BCYCBICYCLE THERAPEUTICS PLC$83.4M3.50%$30.00$4.35-85.5%
3.5%
VRNAVERONA PHARMA PLC$83.3M3.50%β€”β€”
3.5%
BIIBBIOGEN INC$83.1M3.49%$272.63$216.12-20.7%
3.5%
SWTXSPRINGWORKS THERAPEUTICS INC$80.9M3.40%β€”β€”
3.4%
KDNYCHINOOK THERAPEUTICS INC$78.6M3.30%β€”β€”
3.3%
SRPTSAREPTA THERAPEUTICS INC$68.5M2.87%$124.84$19.28-84.6%
2.9%
AGENAGENUS INC$64.8M2.72%$47.11$3.49-92.6%
2.7%
FDMT4D MOLECULAR THERAPEUTICS IN$59.0M2.48%$20.64$13.00-37.0%
2.5%
HZNPHORIZON THERAPEUTICS PUB L$56.9M2.39%β€”β€”
2.4%
HZNPPUTHORIZON THERAPEUTICS PUB L$56.9M2.39%β€”β€”
2.4%
DICEDICE THERAPEUTICS INC$54.1M2.27%β€”β€”
2.3%
VRDNVIRIDIAN THERAPEUTICS INC$51.7M2.17%$28.50$19.40-31.9%
2.2%
ETNB89BIO INC$49.0M2.06%β€”β€”
2.1%
BEAMBEAM THERAPEUTICS INC$45.6M1.92%$37.32$34.79-6.8%
1.9%
IONSIONIS PHARMACEUTICALS INC$45.5M1.91%$37.58$81.80+117.7%
1.9%
ALLKALLAKOS INC$41.3M1.73%β€”β€”
1.7%
RPTXREPARE THERAPEUTICS INC$40.1M1.68%β€”β€”
1.7%
ALBOALBIREO PHARMA INC$36.8M1.55%β€”β€”
1.6%
PLRXPLIANT THERAPEUTICS INC$33.5M1.41%$19.00$1.17-93.8%
1.4%
DYNDYNE THERAPEUTICS INC$31.1M1.31%$11.70$23.07+97.2%
1.3%
ASNDCALLASCENDIS PHARMA A/S$30.4M1.28%$120.72$274.50+127.4%
1.3%
EWTXEDGEWISE THERAPEUTICS INC$30.2M1.27%$8.79$39.56+350.1%
1.3%
SLNSILENCE THERAPEUTICS PLC$29.8M1.25%$14.69$10.39-29.3%
1.3%
AUTLAUTOLUS THERAPEUTICS PLC$28.5M1.20%$1.87$1.58-15.5%
1.2%

AttivitΓ  Trimestre su Trimestre

Q4 2022 vs. Q3 2022

Nuove Posizioni (8)

TickerEmittenteNozionaleDal Deposito
INSMINSMED INC$85.2M+481.9%
BIIBBIOGEN INC$83.1M-20.7%
SRPTSAREPTA THERAPEUTICS INC$68.5M-84.6%
IONSIONIS PHARMACEUTICALS INC$45.5M+117.7%
AUTLAUTOLUS THERAPEUTICS PLC$28.5M-15.5%
ATXSASTRIA THERAPEUTICS INC$27.1M
RAPTRAPT THERAPEUTICS INC$25.8M
DVAXDYNAVAX TECHNOLOGIES CORP$24.8M

Posizioni Chiuse (8)

TickerEmittenteNozionale
NVCRNOVOCURE LTD$98.3M
KURAKURA ONCOLOGY INC$43.5M
FATEFATE THERAPEUTICS INC$29.4M
AKROAKERO THERAPEUTICS INC$26.9M
VERVVERVE THERAPEUTICS INC$26.6M
KALVKALVISTA PHARMACEUTICALS INC$26.5M
GBTGLOBAL BLOOD THERAPEUTICS IN$22.2M
FMTXFORMA THERAPEUTICS HLDGS INC$19.3M

Aumentate (8)

TickerEmittenteNozionaleVar. Azioni
RLMDRELMADA THERAPEUTICS INC$5.6M+2321.3%
RLMDRELMADA THERAPEUTICS INC$-7.2M+515.8%
ISEEIVERIC BIO INC$132.8M+293.9%
NTLAINTELLIA THERAPEUTICS INC$7.6M+133.3%
DICEDICE THERAPEUTICS INC$33.8M+73.4%
ALBOALBIREO PHARMA INC$15.3M+53.4%
ETNB89BIO INC$33.8M+46.1%
SWTXSPRINGWORKS THERAPEUTICS INC$13.3M+31.3%

Ridotte (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
RETACALLREATA PHARMACEUTICALS INC$-7.5M-96.0%
AUPHAURINIA PHARMACEUTICALS INC$-41.3M-94.3%
HOOKHOOKIPA PHARMA INC$-5.7M-75.4%
ASNDCALLASCENDIS PHARMA A/S$-72.8M-75.1%+127.4%
BMRNBIOMARIN PHARMACEUTICAL INC$-43.0M-74.3%
ASNDCALLASCENDIS PHARMA A/S$-52.2M-68.8%+127.4%
HZNPPUTHORIZON THERAPEUTICS PUB L$-33.6M-65.8%
HZNPPUTHORIZON THERAPEUTICS PUB L$-33.6M-65.8%
← Torna agli Hedge Fund